NO973241D0 - Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b - Google Patents

Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b

Info

Publication number: NO973241D0
Authority: NO; Norway
Prior art keywords: diphenylchromanes; hyperlipoproteinemia; hypertriglyceridemia; hypercholesterolemia; hyperlipidemia
Prior art date: 1995-01-13

Application number

NO973241A

Other languages

English (en)

Other versions

NO973241L (no

Inventor

Michael Shalmi

Niels Korsgaard

Steven Bain

Birgitte Hjort Guldhammer

Jan Ulrik Weis

Charles E Hart

Original Assignee

Novo Nordisk As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-01-13

Filing date

1997-07-11

Publication date

1997-07-11

1997-07-11 Application filed by Novo Nordisk As filed Critical Novo Nordisk As

1997-07-11 Publication of NO973241D0 publication Critical patent/NO973241D0/no

1997-07-11 Publication of NO973241L publication Critical patent/NO973241L/no

Links

208000031226 Hyperlipidaemia Diseases 0.000 title 2
FNIBSWRSKVEZDZ-UHFFFAOYSA-N 3,4-diphenyl-3,4-dihydro-2h-chromene Chemical class C1OC2=CC=CC=C2C(C=2C=CC=CC=2)C1C1=CC=CC=C1 FNIBSWRSKVEZDZ-UHFFFAOYSA-N 0.000 title 1
206010003210 Arteriosclerosis Diseases 0.000 title 1
208000035150 Hypercholesterolemia Diseases 0.000 title 1
239000003146 anticoagulant agent Substances 0.000 title 1
229940127219 anticoagulant drug Drugs 0.000 title 1
208000011775 arteriosclerosis disease Diseases 0.000 title 1
208000020346 hyperlipoproteinemia Diseases 0.000 title 1
208000006575 hypertriglyceridemia Diseases 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000011321 prophylaxis Methods 0.000 title 1
238000011282 treatment Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Obesity (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrane Compounds (AREA)

NO973241A 1995-01-13 1997-07-11 Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b NO973241L (no)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
DK4195		1995-01-13
DK4395		1995-01-13
DK6995		1995-01-20
DK76795		1995-06-30
DK76695		1995-06-30
DK77795		1995-06-30
PCT/DK1996/000014 WO1996021443A1 (en)	1995-01-13	1996-01-10	Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of hyperlipoproteinaemia, hypertriglyceridaemia, hyperlipidaemia or hypercholesterolaemia or arteriosclerosis or for anticoagulative treatment

Publications (2)

Publication Number	Publication Date
NO973241D0 true NO973241D0 (no)	1997-07-11
NO973241L NO973241L (no)	1997-07-11

Family

ID=27545138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO973241A NO973241L (no)	1995-01-13	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b

Country Status (11)

Country	Link
EP (1)	EP0804189A1 (no)
JP (1)	JPH10511961A (no)
CN (1)	CN1168098A (no)
AU (1)	AU4329296A (no)
BR (1)	BR9606890A (no)
CA (1)	CA2208859A1 (no)
CZ (1)	CZ212397A3 (no)
HU (1)	HUP9800521A3 (no)
IL (1)	IL116745A (no)
NO (1)	NO973241L (no)
WO (1)	WO1996021443A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5407955A (en) *	1994-02-18	1995-04-18	Eli Lilly And Company	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis
AU3023999A (en) *	1998-03-20	1999-10-18	Novo Nordisk A/S	Use of 3,4-diphenylchromans for the manufacture of a pharmaceutical composition for lowering plasma levels of lp(a) in a human or sub-human primate
US6465445B1 (en) *	1998-06-11	2002-10-15	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en)	1998-06-11	2006-02-28	Endorecherche, Inc.	Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
US8080675B2 (en)	2004-09-21	2011-12-20	Marshall Edwards, Inc.	Chroman derivatives, medicaments and use in therapy
CA2581316C (en)	2004-09-21	2013-09-10	Novogen Research Pty Ltd	Substituted chroman derivatives, medicaments and use in therapy
EP2635273B1 (en)	2010-11-01	2020-01-08	MEI Pharma, Inc.	Isoflavonoid compositions and methods for the treatment of cancer
MX368063B (es)	2014-02-07	2019-09-18	Novogen ltd	Compuestos de benzopirano funcionalizados y uso de los mismos.
CN116139125A (zh)	2015-02-02	2023-05-23	梅制药公司	联合治疗

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1543749A1 (de) *	1966-02-16	1969-12-11	Merck Ag E	Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen
US5407955A (en) *	1994-02-18	1995-04-18	Eli Lilly And Company	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

1996
- 1996-01-10 EP EP96900095A patent/EP0804189A1/en not_active Withdrawn
- 1996-01-10 HU HU9800521A patent/HUP9800521A3/hu unknown
- 1996-01-10 WO PCT/DK1996/000014 patent/WO1996021443A1/en not_active Ceased
- 1996-01-10 BR BR9606890A patent/BR9606890A/pt not_active Application Discontinuation
- 1996-01-10 CA CA002208859A patent/CA2208859A1/en not_active Abandoned
- 1996-01-10 AU AU43292/96A patent/AU4329296A/en not_active Abandoned
- 1996-01-10 JP JP8521377A patent/JPH10511961A/ja active Pending
- 1996-01-10 CN CN96191417A patent/CN1168098A/zh active Pending
- 1996-01-10 CZ CZ972123A patent/CZ212397A3/cs unknown
- 1996-01-12 IL IL11674596A patent/IL116745A/xx not_active IP Right Cessation
1997
- 1997-07-11 NO NO973241A patent/NO973241L/no unknown

Also Published As

Publication number	Publication date
JPH10511961A (ja)	1998-11-17
CZ212397A3 (en)	1997-11-12
HUP9800521A2 (hu)	1998-12-28
BR9606890A (pt)	1997-10-28
IL116745A (en)	1999-12-22
HUP9800521A3 (en)	1999-12-28
AU4329296A (en)	1996-07-31
MX9705214A (es)	1997-10-31
IL116745A0 (en)	1996-05-14
EP0804189A1 (en)	1997-11-05
CA2208859A1 (en)	1996-07-18
NO973241L (no)	1997-07-11
WO1996021443A1 (en)	1996-07-18
CN1168098A (zh)	1997-12-17

Similar Documents

Publication	Publication Date	Title
NO982302D0 (no)	1998-05-20	Farmas÷ytisk sammensetning
FI962589L (fi)	1996-08-20	2,4-disulfofenyylibutyylinitroni, sen suolat ja niiden käyttö farmaseuttisina aineina
DE69101931D1 (de)	1994-06-16	Pharmazeutische Zusammensetzung.
FI955144A0 (fi)	1995-10-27	Päällystetyt farmaseuttiset koostumukset
NO973612D0 (no)	1997-08-05	Nytt farmasöytisk preparat
NO20004345D0 (no)	2000-09-01	Farmasøytisk sammensetning
NO943888D0 (no)	1994-10-14	Farmasöytisk preparat
FI943565A7 (fi)	1994-07-29	Uusia veren hyytymistä estäviä polypeptidejä, niiden valmistus ja niit ä sisältävä farmaseuttinen koostumus
NO954694D0 (no)	1995-11-21	Doseringsform for antidepressiva
EE9800065A (et)	1998-08-17	5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
NO973243D0 (no)	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av gynekologiske sykdommer
NO973241D0 (no)	1997-07-11	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av hyperlipoproteinemi, hypertriglyceridemi, hyperlipidemi eller hyperkolesterolemi, eller arteriosklerose, eller for antikoagulativ b
NO20041007L (no)	2004-03-10	Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
EE04681B1 (et)	2006-08-15	3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
EE9800109A (et)	1998-10-15	5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks
FR2697155B1 (fr)	1994-12-23	Prothèse totale métatarso-phalangienne de surfaçage.
FI972988A0 (fi)	1997-07-14	Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI973229A0 (fi)	1997-08-05	Uusi farmaseuttinen koostumus
LV11727A (lv)	1997-04-20	Farmaceitiska kompozicija
EE03996B1 (et)	2003-04-15	Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
NO973342D0 (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av cerebrale degenerative sykdommer
EE03514B1 (et)	2001-10-15	Ühendite kombinatsioon HIV infektsiooni või AIDS-i raviks, selle kasutamine ja farmatseutiline kompositsioon
NO973340D0 (no)	1997-07-18	Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme
FI973280A0 (fi)	1997-08-08	Farmaseuttinen koostumus
FI944751L (fi)	1995-04-12	Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia